|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.17 0.00 (0.00%) as of 4:30 Mon 4/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
5,670,000 |
| Market
Cap: |
970.14(K) |
| Last
Volume: |
38,510 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1711 - $0.1711 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Diffusion Pharmaceuticals is a clinical stage biotechnology company. Co. is developing its primary product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC). TSC is designed to selectively target and re-oxygenate the micro-environment of hypoxic cells, and can potentially be used in various indications, including stroke, oncology and cardiovascular disease. Co.'s oncology program targets TSC against treatment-resistant brain cancer. In addition to the TSC programs, Co. is exploring alternatives to capitalize upon its product candidate RES-529, a PI3K/Akt/mTOR pathway inhibitor for age-related macular degeneration.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
36 |
36 |
36 |
36 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(121) |
1,204 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
327 |
1,325 |
|
- |
|
| Hollingsworth Jane H |
Director |
• • – |
2022-05-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(67) |
771 |
|
- |
|
| Hollingsworth Jane H |
Director |
• • – |
2022-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
183 |
838 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-05-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(121) |
998 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
327 |
1,119 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-04-18 |
4 |
OE |
$25.00 |
$2,500 |
D/D |
100 |
792 |
|
- |
|
| Elder William Robert |
GC & Secretary |
• • – |
2022-04-18 |
4 |
OE |
$25.00 |
$2,500 |
D/D |
100 |
400 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,049) |
34,602 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,350 |
40,651 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2021-11-01 |
4/A |
D |
$0.00 |
$0 |
D/D |
(6,049) |
24,301 |
|
- |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,350 |
30,350 |
|
- |
|
| Hollingsworth Jane H |
Director |
• • – |
2021-05-13 |
4 |
B |
$0.61 |
$19,999 |
D/D |
32,786 |
32,786 |
2.39 |
-15% |
|
| Elder William Robert |
GC & Secretary |
• • – |
2020-11-17 |
4 |
B |
$0.63 |
$3,150 |
D/D |
5,000 |
15,000 |
2.66 |
37% |
|
| Cobuzzi Robert Joseph Jr. |
President & CEO |
• • – |
2020-11-16 |
4 |
B |
$0.66 |
$9,240 |
D/D |
14,000 |
14,000 |
2.81 |
31% |
|
| Elder William Robert |
GC & Secretary |
• • – |
2020-11-16 |
4 |
B |
$0.67 |
$6,700 |
D/D |
10,000 |
10,000 |
2.74 |
31% |
|
| Galloway Christopher D |
Chief Medical OfficerOfficer |
• – – |
2020-10-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
30,000 |
|
31% |
|
| Giles Mark T |
Director |
• • – |
2016-12-28 |
4 |
B |
$0.00 |
$0 |
I/I |
290,580 |
802,689 |
2.02 |
- |
|
| Giles Mark T |
Director |
• • – |
2016-12-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(290,580) |
0 |
|
- |
|
| Giles Mark T |
Director |
• • – |
2016-12-15 |
4 |
B |
$0.00 |
$0 |
I/I |
512,109 |
512,109 |
2.58 |
- |
|
| Giles Mark T |
Director |
• • – |
2016-12-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(339,055) |
290,580 |
|
- |
|
| Blech Isaac |
Director |
– • – |
2016-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
166,668 |
|
- |
|
| Blech Isaac |
Director |
– • – |
2016-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,334 |
|
- |
|
| Gilliam Richard Baxter |
10% Owner |
– – • |
2016-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,687,975 |
|
- |
|
| Kalergis David G |
Chairman and CEO |
• • – |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
I/I |
215,506 |
215,506 |
|
- |
|
73 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
